Phenylethyl 3,4-dihydroxycinnamate is a potent and specific inhibitor of nuclear transcription factor, NF-κB, activation. It has been shown to significantly suppress the lipoxygenase pathway of arachidonic acid metabolism during inflammation. It inhibits HIV-1 integrase and also inhibits proliferation of transformed cells. It induces apoptosis in transformed fibroblasts, and interferes with EGF signal transduction affecting both protein kinase C and ornithine decarboxylase activity.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Aplicaciones
El feniletil 3,4-dihidroxicinamato es un inhibidor potente y específico de la activación del factor de transcripción nuclear, NF-κB. Se ha demostrado que suprime significativamente la ruta de la lipooxigenasa del metabolismo del ácido araquidónico durante la inflamación. Inhibe la integrasa del VIH-1 y también la proliferación de células transformadas. Induce apoptosis en los fibroblastos transformados e interfiere en la transducción de la señal EGF, lo que afecta tanto a la actividad de la proteína quinasa C como a la ornitina descarboxilasa.
Solubilidad
Soluble en acetato de etilo a 50 mg/ml. Soluble en DMSO y etanol.
Notas
Sensible a la luz. Incompatible con agentes oxidantes y con el calor.
RUO – Research Use Only
General References:
- M.R.Fesen; Y.Pommier; F.Leteurtre; S.Hiroguchi; J.Yung; K.W.Kohn; Mark R.Fesen; Yves Pommier; Francois Leteurtre; Satoshi Hiroguchi; Jessie Yung; Kurt W.Kohn. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochemical Pharmacology. 1994, 48,(3), 595-608.
- Z.S.Zheng; G.Z.Xue; D.Grunberger; J.H.Prystowsky. Caffeic acid phenethyl ester inhibits proliferation of human keratinocytes and interferes with the EGF regulation of ornithine decarboxylase. Oncology Research. 1995, 7,(9), 445-452.